Mannitol Intravenous (Mannitol Injection, USP) should be administered only by intravenous infusion. The total dosage, concentration and rate of administration should be governed by the nature and severity of the condition being treated, fluid requirement and urinary output.
What is mannitol IV used for?
MANNITOL (MAN i tawl) is a diuretic. It is used to reduce pressure and swelling around the brain and in the eyes. It is also used to prevent or treat kidney failure.
Why is mannitol given IV bolus?
Mannitol may be used to reduce intraocular pressure when given intravenously. The mannitol is a new solute in the intravascular space, which increases the tonicity of the blood plasma. The increased tonicity of the blood plasma draws water out of the vitreous humor of the eye and into the intravascular space.
Can mannitol be mixed with normal saline?
No interactions were found between mannitol and Normal Saline Flush. This does not necessarily mean no interactions exist. Always consult your healthcare provider.
How do you administer mannitol IV?
The infusion is given as a 15% to 25% solution over a period of 3 to 5 minutes to produce a urine flow of at least 30 to 50 mL/hour. If urine flow does not increase, a second dose may be given; but if there is inadequate response, the patient should be re-evaluated.
Why mannitol is given?
Mannitol is a diuretic used to force urine production in people with acute (sudden) kidney failure. Mannitol injection is also used to reduce swelling and pressure inside the eye or around the brain.
How does mannitol reduce intracranial pressure?
Mannitol lowers ICP through two distinct effects in the brain. The first, rheological effect, reduces blood viscosity, and promotes plasma expansion and cerebral oxygen delivery. In response, cerebral vasoconstriction occurs due to autoregulation, and cerebral blood volume is decreased.
What are nursing administration considerations for mannitol?
Nursing care of the patient receiving mannitol requires vigilant monitoring of electrolytes and overall fluid balance, and observation for the development of cardiopulmonary complications in addition to neurologic assessment.
How long should mannitol be administered?
Conclusions: Mannitol use every 4 hours per day has evident effect of reducing the intracranial pressure in the 1st, 2nd, 3rd, and 4th day, then mannitol should be used temporarily according to the intracranial pressure after the 5th day. Mannitol should not be used for more than 8 days.
How do you prescribe mannitol?
The general dose range is 50 to 200 g mannitol (500 ml to 2000 ml/day) in a 24 hour period, with a dosage limit of 50 g (500ml mannitol) on any one occasion. In most instances, adequate response will be achieved at a dosage of 50 to 100 g mannitol/day (500 ml to 1000 ml /day).
What is mannitol infusion?
Mannitol I.V. (mannitol injection) is a diuretic used to increase urine production, and to treat or prevent medical conditions that are caused by an increase in body fluids/water (e.g., cerebral edema, glaucoma, kidney failure). Mannitol I.V. is available in generic form.
What is a 25% mannitol injection?
Mannitol Injection, USP, 25%, an osmotic diuretic, is a sterile, nonpyrogenic solution of mannitol in Water for Injection. It is a supersaturated solution at room temperature.
Is mannitol (mannitol) injection safe during pregnancy?
Pregnancy Category C. It is also not known whether mannitol (mannitol (mannitol injection) injection) injection can cause fetal harm when given to a pregnant woman or can affect reproduction. Mannitol (mannitol (mannitol injection) injection) injection should be given to a pregnant woman only if clearly needed.
What precautions should be taken when infusing mannitol?
When infusing 20% or 25% mannitol (mannitol (mannitol injection) injection) concentrations, the administration set should include a filter. Exposure of pharmaceutical products to heat should be minimized. Avoid excessive heat. Protect from freezing.
What is the concentration of mannitol in water?
Mannitol intravenous (Mannitol Injection, USP) is a sterile, nonpyrogenic solution of mannitol in water for injection available in a concentration of 25% in a fliptop vial for administration by intravenous infusion only. The content and characteristics are as follows: Conc. (%) g/100 mL mOsmol/liter (calc.) pH*
